FIELD: organic chemistry, chemical technology, medicine, endocrinology.
SUBSTANCE: invention relates to a method for preparing an antidiabetic agent pioglitazone of the formula (I): . Method involves condensation of 4-substituted phenol or phenolate of the general formula (II):
wherein R represents organic radical comprising amino-group and chosen from group comprising group of the general formula: -NHRa (IIa) wherein Ra means hydrogen atom or protective group that is removed before the following treatment, and group of the general formula:
wherein Rb represents carboxyl group as free acid or as salt or ester; M represents hydrogen atom or alkaline metal with pyridine base of the general formula (III):
wherein Z means a removing group distinguishing from halogen atom and wherein the following steps are carried out: (a) diazotization reaction of amino-group as a moiety of organic radical R; (b) conversion of diazotized radical R to derivative of 2-halogenpropionate or 2-halogenpropionitrile of the formula:
wherein Rb is determined above; X represents halogen atom; (c) cyclization of derivative of 2-halogenpropionate or 2-halogenpropionitrile with thiourea, and (d) hydrolysis of imine prepared. In case when R represents group of the formula (IIa) method involves firstly carrying out the condensation reaction followed by carrying out steps (a)-(d) to obtain agent of the formula (I); or in case when R represents group of the formula (IIb) then method involves firstly carrying out steps (a)-(d) followed by condensation with pyridine base of the general formula (III) to obtain agent of the formula (I). Also, invention describes compounds of the formula (V):
wherein Ra represents a protective group chosen from group comprising acyl, n-alkoxycarbonyl, tert.-butoxycarbonyl, benzyloxycarbonyl, 9-fluorenylmethoxycarbonyl, allyloxycarbonyl, 2-cyanoethoxycarbonyl as an intermediate substance in synthesis of compound of the formula (I).
EFFECT: improved preparing method of agent.
12 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF THIAZOLIDINEDIONE, THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2129553C1 |
METHOD FOR PREPARING {2-[4-(ALPHA-PHENYL-PARA-CHLOROBENZYL)PIPERAZINE-1-YL]ETHOXY}-ACETIC ACID AND NEW INTERMEDIATE COMPOUNDS | 2000 |
|
RU2248974C2 |
DERIVATIVES OF QUINAZOLINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND METHOD OF ACHIEVEMENT OF ANTI-ANGIOGENIC EFFECT AND/OR EFFECT OF DECREASE OF VASCULAR PENETRATION WITH THEIR USING | 1996 |
|
RU2194701C2 |
1,3-DIOXANE DERIVATIVES OF ALKENOIC ACID OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT | 1989 |
|
RU2040525C1 |
METHOD OF PRODUCING DERIVATIVES OF THIOZOLIDINEDIONE OR THEIR SODIUM SALTS | 0 |
|
SU1496634A3 |
HETEROCYCLIC DERIVATIVES OR THEIR SALTS WITH ACIDS OR BASES | 1990 |
|
RU2049784C1 |
METHOD FOR PREPARING RETINAL OR ADDUCT (COMPLETE-E)-RETINAL WITH HYDROQUINONE AND INTERMEDIATE SUBSTANCES | 2002 |
|
RU2318805C2 |
DERIVATIVES OF 1,3-DIOXANE ALKENOIC ACID | 1989 |
|
RU2045526C1 |
DERIVATIVES OF INDANE ACETIC ACID AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2314298C2 |
BENZIMIDAZOLE DERIVATIVES, TAUTOMERS OR SALTS THEREOF AND DRUG HAVING ANTAGONISTIC ANGIOTENSINE II EFFECT | 1993 |
|
RU2126401C1 |
Authors
Dates
2006-08-10—Published
2002-04-25—Filed